NASDAQ:ADMA
ADMA Biologics Inc Stock News
$6.46
-0.0800 (-1.22%)
At Close: Apr 24, 2024
Why Adma Biologics Stock Crushed the Market on Friday
06:29pm, Friday, 17'th Nov 2023
The Food and Drug Administration approved the company's tenth plasma-collection facility. This is located in Maryland.
Why Adma Biologics Was Trouncing the Market Today
04:25pm, Thursday, 09'th Nov 2023
The biotech published its third-quarter results after market close on Wednesday. Revenue growth was strong, while the bottom line did a nice flip into the black.
ADMA Biologics, Inc. (ADMA) Q3 2023 Earnings Call Transcript
07:11pm, Wednesday, 08'th Nov 2023
ADMA Biologics, Inc. (NASDAQ:ADMA ) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET Company Participants Skyler Bloom - Head, Business Development & Corporate Strategy Adam Grossman – P
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
06:47pm, Thursday, 02'nd Nov 2023
Adma Biologics (ADMA) closed the most recent trading day at $3.45, moving -1.99% from the previous trading session.
Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note
06:48pm, Friday, 27'th Oct 2023
Adma Biologics (ADMA) closed at $3.31 in the latest trading session, marking a +0.91% move from the prior day.
Adma Biologics (ADMA) Rises As Market Takes a Dip: Key Facts
07:33pm, Tuesday, 17'th Oct 2023
In the most recent trading session, Adma Biologics (ADMA) closed at $3.44, indicating a +1.78% shift from the previous trading day.
Adma Biologics (ADMA) Stock Sinks As Market Gains: Here's Why
07:33pm, Monday, 09'th Oct 2023
In the closing of the recent trading day, Adma Biologics (ADMA) stood at $3.34, denoting a -0.3% change from the preceding trading day.
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views?
10:31am, Wednesday, 13'th Sep 2023
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
Why Shares of ADMA Biologics Are Climbing Thursday
02:31pm, Thursday, 10'th Aug 2023
ADMA grew revenue and trimmed its losses compared to the same quarter a year ago. The company increased revenue guidance for 2023, 2024, and 2025.
ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023
07:00am, Wednesday, 02'nd Aug 2023
RAMSEY, N.J. and BOCA RATON, Fla.
ADMA Biologics (ADMA) to Report Q2 Earnings: What's in Store?
10:15am, Friday, 28'th Jul 2023
On ADMA Biologics' (ADMA) Q2 earnings call, investors will likely focus on the sales performance of its immune deficiency disorder drugs.
New Strong Buy Stocks for July 7th
08:37am, Friday, 07'th Jul 2023
ADMA, APOG, KIND, JBL and OII have been added to the Zacks Rank #1 (Strong Buy) List on July 7, 2023.
GSK Announces Extension of FDA Review for Rare Blood Therapy
11:43am, Monday, 19'th Jun 2023
GSK announces the FDA's extension of the review period of its new drug application for momelotinib to treat myelofibrosis by three months. A decision is now expected on Sep 16, 2023.
ADMA Biologics: An Emerging Growth Play
02:15pm, Thursday, 15'th Jun 2023
Today, we take a deeper look at ADMA Biologics, Inc., whose stock has doubled over the past year thanks to robust sales growth. The company continues to expand its plasma collection network, is delive
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
10:50am, Monday, 29'th May 2023
Here is how Adma Biologics (ADMA) and Novartis (NVS) have performed compared to their sector so far this year.
